FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3080466051> ?p ?o ?g. }

• W3080466051 endingPage "2369" @default.
• W3080466051 startingPage "2369" @default.
• W3080466051 abstract "Photodynamic therapy (PDT) is an attractive cancer treatment modality. Talaporfin sodium, a second-generation photosensitizer, results in lower systemic toxicity and relatively better selective tumor destruction than first-generation photosensitizers. However, the mechanism through which PDT induces vascular shutdown is unclear. In this study, the in vitro effects of talaporfin sodium-based PDT on human umbilical vein endothelial cells (HUVECs) were determined through cell viability and endothelial tube formation assays, and evaluation of the tubulin and F-actin dynamics and myosin light chain (MLC) phosphorylation. Additionally, the effects on tumor blood flow and tumor vessel destruction were assessed in vivo. In the HUVECs, talaporfin sodium-based PDT induced endothelial tube destruction and microtubule depolymerization, triggering the formation of F-actin stress fibers and a significant increase in MLC phosphorylation. However, pretreatment with the Rho-associated protein kinase (ROCK) inhibitor, Y27632, completely prevented PDT-induced stress fiber formation and MLC phosphorylation. The in vivo analysis and pathological examination revealed that the PDT had significantly decreased the tumor blood flow and the active area of the tumor vessel. We concluded that talaporfin sodium-based PDT induces the shutdown of existing tumor vessels via the RhoA/ROCK pathway by activating the Rho-GTP pathway and decreasing the tumor blood flow." @default.
• W3080466051 created "2020-09-01" @default.
• W3080466051 creator A5042213269 @default.
• W3080466051 creator A5047369080 @default.
• W3080466051 creator A5050875751 @default.
• W3080466051 creator A5057744447 @default.
• W3080466051 creator A5068785582 @default.
• W3080466051 creator A5089158000 @default.
• W3080466051 date "2020-08-21" @default.
• W3080466051 modified "2023-10-04" @default.
• W3080466051 title "Vascular Shutdown by Photodynamic Therapy Using Talaporfin Sodium" @default.
• W3080466051 cites W1481039042 @default.
• W3080466051 cites W1528756088 @default.
• W3080466051 cites W1543670377 @default.
• W3080466051 cites W1547037881 @default.
• W3080466051 cites W1596848781 @default.
• W3080466051 cites W1779922929 @default.
• W3080466051 cites W1839329789 @default.
• W3080466051 cites W1965047219 @default.
• W3080466051 cites W1966726954 @default.
• W3080466051 cites W1990644600 @default.
• W3080466051 cites W1990901955 @default.
• W3080466051 cites W1992354862 @default.
• W3080466051 cites W1994227923 @default.
• W3080466051 cites W2007668137 @default.
• W3080466051 cites W2010635066 @default.
• W3080466051 cites W2011677813 @default.
• W3080466051 cites W2018987388 @default.
• W3080466051 cites W2028959660 @default.
• W3080466051 cites W2037000177 @default.
• W3080466051 cites W2038497586 @default.
• W3080466051 cites W2038713593 @default.
• W3080466051 cites W2039169563 @default.
• W3080466051 cites W2064296350 @default.
• W3080466051 cites W2071689403 @default.
• W3080466051 cites W2084393946 @default.
• W3080466051 cites W2085742024 @default.
• W3080466051 cites W2087481696 @default.
• W3080466051 cites W2097917131 @default.
• W3080466051 cites W2103763724 @default.
• W3080466051 cites W2109645616 @default.
• W3080466051 cites W2110722654 @default.
• W3080466051 cites W2121286455 @default.
• W3080466051 cites W2129339346 @default.
• W3080466051 cites W2140444363 @default.
• W3080466051 cites W2143346649 @default.
• W3080466051 cites W2147490767 @default.
• W3080466051 cites W2148309788 @default.
• W3080466051 cites W2148990197 @default.
• W3080466051 cites W2165094789 @default.
• W3080466051 cites W2171391552 @default.
• W3080466051 cites W2414536117 @default.
• W3080466051 cites W2563170362 @default.
• W3080466051 cites W2566433825 @default.
• W3080466051 cites W2747765631 @default.
• W3080466051 cites W2782385016 @default.
• W3080466051 cites W2915325238 @default.
• W3080466051 cites W2952566998 @default.
• W3080466051 cites W2964919819 @default.
• W3080466051 cites W2969159587 @default.
• W3080466051 cites W4230026896 @default.
• W3080466051 doi "https://doi.org/10.3390/cancers12092369" @default.
• W3080466051 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7563359" @default.
• W3080466051 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32825648" @default.
• W3080466051 hasPublicationYear "2020" @default.
• W3080466051 type Work @default.
• W3080466051 sameAs 3080466051 @default.
• W3080466051 citedByCount "20" @default.
• W3080466051 countsByYear W30804660512021 @default.
• W3080466051 countsByYear W30804660512022 @default.
• W3080466051 countsByYear W30804660512023 @default.
• W3080466051 crossrefType "journal-article" @default.
• W3080466051 hasAuthorship W3080466051A5042213269 @default.
• W3080466051 hasAuthorship W3080466051A5047369080 @default.
• W3080466051 hasAuthorship W3080466051A5050875751 @default.
• W3080466051 hasAuthorship W3080466051A5057744447 @default.
• W3080466051 hasAuthorship W3080466051A5068785582 @default.
• W3080466051 hasAuthorship W3080466051A5089158000 @default.
• W3080466051 hasBestOaLocation W30804660511 @default.
• W3080466051 hasConcept C11960822 @default.
• W3080466051 hasConcept C123012128 @default.
• W3080466051 hasConcept C150903083 @default.
• W3080466051 hasConcept C178790620 @default.
• W3080466051 hasConcept C185592680 @default.
• W3080466051 hasConcept C201800478 @default.
• W3080466051 hasConcept C202751555 @default.
• W3080466051 hasConcept C207001950 @default.
• W3080466051 hasConcept C2777093181 @default.
• W3080466051 hasConcept C2777411675 @default.
• W3080466051 hasConcept C2781323092 @default.
• W3080466051 hasConcept C2781469039 @default.
• W3080466051 hasConcept C502942594 @default.
• W3080466051 hasConcept C55493867 @default.
• W3080466051 hasConcept C62478195 @default.
• W3080466051 hasConcept C86803240 @default.
• W3080466051 hasConcept C95444343 @default.
• W3080466051 hasConceptScore W3080466051C11960822 @default.
• W3080466051 hasConceptScore W3080466051C123012128 @default.

• next